RefleXion Medical
By leveraging positron emission tomography (PET), the gold standard in cancer imaging and staging in a novel way, RefleXion’s patented technology* causes tumors to continuously signal their location during radiotherapy.
Launch date
Employees
Market cap
-
Enterprise valuation
$550m (Public information from Nov 2023)
Hayward California (HQ)
Authorizing premium user...